Södersjukhuset
Stockholm, 11883, Sweden
NCT Number: NCT05650463
A cross-sectional study at the Södersjukehuset facility (Stockholm, Sweden) collect data of newborns from a population with Neomar scale type 4 to adjust the algorithm of Picterus JP
Looking for future studies?
Notify Me1 day–14 day
All sexes
Interventional
Not applicable
Stockholm, 11883, Sweden
To adjust Picterus JP to work in newborns with more pigmented skin, the investigators will collect a data set at Sachsska barnsjukhuset Södersjukhuset, Stockholm Sweden from 150 newborns with dark skins using Picterus JP, TcB, skin measurements from a spectrometer, visual assessment, and total serum bilirubin (TSB) levels. As a control, newborns with Neomar scale 1-3 will be included.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.
Time frame: 6 months
Evaluate of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with Neomar neonatal skin color scale type 4 (with type 1 being lower-melanin level and Type 4 being higher-melanin level)
Time frame: 1-2 hours
Compare bilirubin estimates calculated with the adjusted algoritm from the images with TSB measurements
Time frame: 5-10min
Compare bilirubin estimates calculated with the adjusted algoritm from the images with TcB measurements
Time frame: 5-10min
Compare bilirubin estimates calculated with the adjusted algoritm from the images with visual assessment.
Picterus AS
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06687746
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Hodal, India
View Trial DetailsNCT03741803
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Houston, Texas, United States
View Trial DetailsNCT07388732
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyper Bilirubinemia
Kütahya, Province, Turkey (Türkiye)
View Trial DetailsNCT03805165
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Guangzhou, Guangdong, China
View Trial Details